NCT04902417Completed
Dairy and Inflammation Study
Influence of Increased Dairy Product Consumption on Markers of Inflammation and Cardiometabolic Disease
Source: ClinicalTrials.gov · Last updated 16 Jan 2026
Brief summary (registry, in English)
The purpose of this study is to determine whether 6-weeks of increased dairy consumption can reduce inflammation and other markers of chronic disease while fasted or following a high-fat meal.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 11 May 2021
- Start date
- 1 May 2022
- Primary completion date
- 30 Mar 2024
- Lead sponsor
- York University
- Diseases
- Obesity
- NCT number
- NCT04902417
What you commit to
- Study type: Interventional
- Participants enrolled: 32
- From 1 May 2022 to the primary completion date, 30 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous history of diabetes and/or related cardiovascular disease
Other illness
- Allergy to dairy foods, diagnosed lactose intolerance or an aversion to foods provided during the study
Lab values
- The use of multiple medications for managing lipids, glucose and/or blood pressure
Who the study is looking for
- Body mass index (BMI) ≥ 25 kg/m2
- ≤ 2 structured exercise sessions/week
- Habitual low dairy consumption (≤ 1 serving/day)
- Having at least two other metabolic risk factors based on clinical guidelines:
- Elevated blood pressure (≥130/≥85 mm Hg)
- Impaired fasting glucose (≥5.6 mmol/L) measured using a finger prick sample
- Impaired fasting triglycerides (≥1.7 mmol/L) or high-density lipoprotein (\<1.03 mmol/L for males, \<1.3 mmol/L for females) measured using a finger prick blood sample.
- Increased waist circumference (≥102 cm for males and ≥88 cm for females).
- Borderline high fasting low-density lipoprotein (≥3.5 mmol/L) or total cholesterol (≥5.2 mmol/L).
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| York University Coordinator of this site? Confirm its status | Toronto | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.